Cariprazine (VRAYLAR®) Met Primary Endpoint in Phase 3 Study as an Adjunctive Treatment for Major Depressive Disorder
29/10/2021
Business related Central Nervous System News - Cariprazine PARTNER - ALLERGAN / ABBVIE / ACTAVIS PRODUCT - VRAYLAR R&D trial
592 kb 29/10/2021 pdf